X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-11-15 | RXST | Rxsight, Inc. | Goldshleger Ilya | See remarks | S - Sale+OE | $45.61 | -7,975 | 43,618 | -15% | -$363,752 | |||||
| D | 2024-11-12 | RXST | Rxsight, Inc. | Goldshleger Ilya | See remarks | S - Sale+OE | $46.13 | -1,330 | 43,618 | -3% | -$61,356 | |||||
| M | 2024-11-12 | RXST | Rxsight, Inc. | Corley Jesse Anderson | Dir | P - Purchase | $45.14 | +22,476 | 538,370 | +4% | +$1,014,570 | |||||
| D | 2024-11-07 | RXST | Rxsight, Inc. | Goldshleger Ilya | See remarks | S - Sale+OE | $55.00 | -3,100 | 43,618 | -7% | -$170,495 | |||||
| D | 2024-11-04 | RXST | Rxsight, Inc. | Goldshleger Ilya | See remarks | S - Sale+OE | $51.05 | -3,100 | 43,618 | -7% | -$158,247 | |||||
| D | 2024-10-30 | RXST | Rxsight, Inc. | Goldshleger Ilya | See remarks | S - Sale+OE | $51.91 | -3,105 | 43,618 | -7% | -$161,171 | |||||
| DM | 2024-10-25 | RXST | Rxsight, Inc. | Goldshleger Ilya | See remarks | S - Sale+OE | $50.22 | -6,200 | 43,618 | -12% | -$311,354 | |||||
| D | 2024-10-22 | RXST | Rxsight, Inc. | Goldshleger Ilya | See remarks | S - Sale+OE | $49.68 | -3,100 | 43,618 | -7% | -$154,001 | |||||
| DM | 2024-10-16 | RXST | Rxsight, Inc. | Goldshleger Ilya | See remarks | S - Sale+OE | $49.94 | -6,205 | 43,618 | -12% | -$309,850 | |||||
| DM | 2024-10-10 | RXST | Rxsight, Inc. | Goldshleger Ilya | See remarks | S - Sale+OE | $49.70 | -9,305 | 43,618 | -18% | -$462,458 | |||||
| DM | 2024-10-04 | RXST | Rxsight, Inc. | Goldshleger Ilya | See remarks | S - Sale+OE | $48.13 | -6,200 | 43,618 | -12% | -$298,437 | |||||
| D | 2024-10-01 | RXST | Rxsight, Inc. | Thunen Shelley B | See remarks | S - Sale+OE | $48.45 | -15,000 | 30,443 | -33% | -$726,730 | |||||
| DM | 2024-09-26 | RXST | Rxsight, Inc. | Goldshleger Ilya | See remarks | S - Sale+OE | $49.15 | -6,205 | 43,618 | -12% | -$305,000 | |||||
| A | 2024-09-20 | LUCY | Innovative Eyewear Inc | Galkin Vladimir | 10% | P - Purchase | $10.31 | +70,000 | 799,208 | +10% | +$721,472 | |||||
| A | 2024-09-20 | LUCY | Innovative Eyewear Inc | Galkin Vladimir | 10% | S - Sale | $10.61 | -14,037 | 799,208 | -2% | -$148,896 | |||||
| A | 2024-09-23 | LUCY | Innovative Eyewear Inc | Galkin Vladimir | 10% | P - Purchase | $9.08 | +200,792 | 1,000,000 | +25% | +$1,822,973 | |||||
| A | 2024-09-19 | LUCY | Innovative Eyewear Inc | Galkin Vladimir | 10% | P - Purchase | $8.91 | +297,443 | 743,245 | +67% | +$2,649,148 | |||||
| A | 2024-09-19 | LUCY | Innovative Eyewear Inc | Galkin Vladimir | 10% | S - Sale | $9.07 | -42,328 | 743,245 | -5% | -$384,100 | |||||
| A | 2024-09-18 | LUCY | Innovative Eyewear Inc | Galkin Vladimir | 10% | P - Purchase | $7.79 | +128,130 | 488,130 | +36% | +$997,896 | |||||
| A | 2024-09-18 | LUCY | Innovative Eyewear Inc | Galkin Vladimir | 10% | S - Sale | $8.17 | -60,000 | 488,130 | -11% | -$490,400 | |||||
| A | 2024-09-17 | LUCY | Innovative Eyewear Inc | Galkin Vladimir | 10% | P - Purchase | $7.12 | +346,736 | 420,000 | +473% | +$2,469,387 | |||||
| A | 2024-09-17 | LUCY | Innovative Eyewear Inc | Galkin Vladimir | 10% | S - Sale | $7.27 | -258,483 | 420,000 | -38% | -$1,879,632 | |||||
2024-09-23 | LUCY | Innovative Eyewear Inc | Galkin Vladimir | 10% | P - Purchase | $9.08 | +200,792 | 1,000,000 | +25% | +$1,822,973 | ||||||
2024-09-20 | LUCY | Innovative Eyewear Inc | Galkin Vladimir | 10% | P - Purchase | $10.31 | +70,000 | 799,208 | +10% | +$721,472 | ||||||
2024-09-20 | LUCY | Innovative Eyewear Inc | Galkin Vladimir | 10% | S - Sale | $10.61 | -14,037 | 799,208 | -2% | -$148,896 | ||||||
2024-09-19 | LUCY | Innovative Eyewear Inc | Galkin Vladimir | 10% | P - Purchase | $8.91 | +297,443 | 743,245 | +67% | +$2,649,148 | ||||||
2024-09-19 | LUCY | Innovative Eyewear Inc | Galkin Vladimir | 10% | S - Sale | $9.07 | -42,328 | 743,245 | -5% | -$384,100 | ||||||
2024-09-18 | LUCY | Innovative Eyewear Inc | Galkin Vladimir | 10% | P - Purchase | $7.79 | +128,130 | 488,130 | +36% | +$997,896 | ||||||
2024-09-18 | LUCY | Innovative Eyewear Inc | Galkin Vladimir | 10% | S - Sale | $8.17 | -60,000 | 488,130 | -11% | -$490,400 | ||||||
2024-09-17 | LUCY | Innovative Eyewear Inc | Galkin Vladimir | 10% | P - Purchase | $7.12 | +346,736 | 420,000 | +473% | +$2,469,387 | ||||||
2024-09-17 | LUCY | Innovative Eyewear Inc | Galkin Vladimir | 10% | S - Sale | $7.27 | -258,483 | 420,000 | -38% | -$1,879,632 | ||||||
| DM | 2024-09-20 | RXST | Rxsight, Inc. | Goldshleger Ilya | See remarks | S - Sale+OE | $52.93 | -6,200 | 43,618 | -12% | -$328,164 | |||||
| D | 2024-09-19 | COO | Cooper Companies, Inc. | White Albert G III | Pres, CEO | S - Sale+OE | $110.53 | -114,992 | 165,273 | -41% | -$12,710,041 | |||||
| D | 2024-09-17 | RXST | Rxsight, Inc. | Goldshleger Ilya | See remarks | S - Sale+OE | $56.11 | -3,100 | 43,618 | -7% | -$173,944 | |||||
2024-09-11 | WRBY | Warby Parker Inc. | Miller Steven Clive | CFO | S - Sale | $13.90 | -6,763 | 177,488 | -4% | -$94,006 | ||||||
| D | 2024-09-10 | COO | Cooper Companies, Inc. | Ricupati Agostino | SVP, CAO | S - Sale+OE | $108.03 | -1,601 | 4,818 | -25% | -$172,955 | |||||
| D | 2024-09-06 | WRBY | Warby Parker Inc. | Miller Steven Clive | CFO | S - Sale+OE | $13.00 | -15,272 | 184,251 | -8% | -$198,536 | |||||
| DM | 2024-09-06 | WRBY | Warby Parker Inc. | Blumenthal Neil Harris | Co-CEO | S - Sale+OE | $13.58 | -77,143 | 412,177 | -16% | -$1,047,484 | |||||
| DM | 2024-09-06 | WRBY | Warby Parker Inc. | Gilboa David Abraham | Co-CEO | S - Sale+OE | $13.44 | -76,177 | 12,306 | -86% | -$1,024,134 | |||||
| D | 2024-09-05 | COO | Cooper Companies, Inc. | Andrews Brian G | EVP, CFO, Treasurer | S - Sale+OE | $105.90 | -24,788 | 15,910 | -61% | -$2,625,072 | |||||
| D | 2024-09-04 | COO | Cooper Companies, Inc. | McBride Daniel G | EVP, COO | S - Sale+OE | $105.49 | -114,992 | 139,192 | -45% | -$12,129,911 | |||||
| D | 2024-08-23 | EYE | National Vision Holdings, Inc. | Moore Patrick R. | Special Advisor | S - Sale+OE | $10.52 | -17,661 | 66,881 | -21% | -$185,794 | |||||
2024-08-19 | LUCY | Innovative Eyewear Inc | Gross Harrison R. | CEO | P - Purchase | $3.68 | +500 | 500 | New | +$1,840 | ||||||
2024-08-12 | STAA | Staar Surgical Co | Butcher Arthur C | Dir | P - Purchase | $37.99 | +1,315 | 4,208 | +45% | +$49,957 | ||||||
| M | 2024-08-13 | WRBY | Warby Parker Inc. | Singer Bradley E | Dir | P - Purchase | $12.88 | +75,000 | 140,793 | +114% | +$965,750 | |||||
2024-08-13 | EYE | National Vision Holdings, Inc. | Peeler D Randolph | Dir | P - Purchase | $10.57 | +25,000 | 250,747 | +11% | +$264,200 | ||||||
2024-08-12 | EYE | National Vision Holdings, Inc. | Hepner Virginia A | Dir | P - Purchase | $10.37 | +1,000 | 36,635 | +3% | +$10,365 | ||||||
2024-08-05 | BLCO | Bausch & Lomb Corp | Saunders Brent L | CEO, COB | P - Purchase | $15.66 | +32,250 | 627,419 | +5% | +$505,067 | ||||||
2024-08-05 | RXST | Rxsight, Inc. | Goldshleger Ilya | See remarks | S - Sale | $39.25 | -9,000 | 43,618 | -17% | -$353,291 | ||||||
| D | 2024-07-01 | RXST | Rxsight, Inc. | Thunen Shelley B | CFO | S - Sale+OE | $58.68 | -18,402 | 13,938 | -57% | -$1,079,816 | |||||
2024-06-14 | WRBY | Warby Parker Inc. | D1 Capital Partners L.P. | 10% | S - Sale | $15.66 | -5,500,000 | 9,471,223 | -37% | -$86,130,000 | ||||||
2024-06-14 | RXST | Rxsight, Inc. | Andrews Julie | Dir | S - Sale | $58.00 | -15,625 | 30,287 | -34% | -$906,288 | ||||||
2024-06-13 | WRBY | Warby Parker Inc. | Briggs Teresa | Dir | S - Sale | $16.31 | -7,396 | 54,828 | -12% | -$120,629 | ||||||
| DM | 2024-06-11 | WRBY | Warby Parker Inc. | Miller Steven Clive | CFO | S - Sale+OE | $16.61 | -109,210 | 173,012 | -39% | -$1,813,790 | |||||
| D | 2024-06-07 | WRBY | Warby Parker Inc. | Blumenthal Neil Harris | Co-CEO | S - Sale+OE | $16.65 | -76,582 | 412,177 | -16% | -$1,275,122 | |||||
| DM | 2024-06-07 | WRBY | Warby Parker Inc. | Gilboa David Abraham | Co-CEO | S - Sale+OE | $16.69 | -175,616 | 12,306 | -93% | -$2,930,499 | |||||
| DM | 2024-06-06 | WRBY | Warby Parker Inc. | Miller Steven Clive | CFO | S - Sale+OE | $16.63 | -85,148 | 182,406 | -32% | -$1,416,048 | |||||
2024-05-17 | RXST | Rxsight, Inc. | Tammenoms Bakker Juliet | Dir | P - Purchase | $61.09 | +5,000 | 36,388 | +16% | +$305,457 | ||||||
2024-05-13 | EYE | National Vision Holdings, Inc. | Fahs L Reade | CEO | P - Purchase | $14.96 | +20,000 | 996,527 | +2% | +$299,200 | ||||||
2024-05-10 | EYE | National Vision Holdings, Inc. | Peeler D Randolph | Dir | P - Purchase | $14.45 | +34,000 | 225,747 | +18% | +$491,198 | ||||||
2024-05-09 | STAA | Staar Surgical Co | Broadwood Partners, L.P. | 10% | P - Purchase | $42.56 | +1 | 21,562,762 | 0% | +$43 | ||||||
2024-05-03 | RXST | Rxsight, Inc. | Kurtz Ronald M Md | Pres, CEO | S - Sale | $60.15 | -40,000 | 804,610 | -5% | -$2,405,872 | ||||||
| D | 2024-05-01 | RXST | Rxsight, Inc. | Thunen Shelley B | CFO | S - Sale+OE | $52.69 | -10,000 | 22,340 | -31% | -$526,913 | |||||
2024-04-01 | RXST | Rxsight, Inc. | Thunen Shelley B | CFO | S - Sale | $49.90 | -20,000 | 22,093 | -48% | -$997,946 | ||||||
| D | 2024-03-18 | COO | Cooper Companies, Inc. | Ricupati Agostino | SVP, CAO | S - Sale+OE | $100.89 | -54,724 | 5,081 | -92% | -$5,521,230 | |||||
2024-03-14 | STAA | Staar Surgical Co | Weisner Aimee S | Dir | P - Purchase | $38.11 | +1,750 | 10,864 | +19% | +$66,693 | ||||||
2024-03-11 | WRBY | Warby Parker Inc. | Miller Steven Clive | CFO | S - Sale | $11.98 | -24,225 | 166,879 | -13% | -$290,216 | ||||||
| DM | 2024-03-07 | COO | Cooper Companies, Inc. | Weiss Robert S | Dir | S - Sale+OE | $102.20 | -241,288 | 578,132 | -29% | -$24,659,342 | |||||
| DM | 2024-03-06 | WRBY | Warby Parker Inc. | Gilboa David Abraham | Co-CEO | S - Sale+OE | $12.09 | -80,376 | 12,306 | -87% | -$971,528 | |||||
| D | 2024-03-06 | WRBY | Warby Parker Inc. | Miller Steven Clive | CFO | S - Sale+OE | $11.88 | -8,708 | 191,104 | -4% | -$103,451 | |||||
| DM | 2024-03-06 | WRBY | Warby Parker Inc. | Blumenthal Neil Harris | Co-CEO | S - Sale+OE | $12.21 | -78,311 | 412,177 | -16% | -$956,335 | |||||
2024-03-05 | COO | Cooper Companies, Inc. | Petersmeyer Gary S | Dir | S - Sale | $103.51 | -1,000 | 9,056 | -10% | -$103,506 | ||||||
2024-03-05 | WRBY | Warby Parker Inc. | Miller Steven Clive | CFO | S - Sale | $12.12 | -8,963 | 178,653 | -5% | -$108,632 | ||||||
2024-03-05 | WRBY | Warby Parker Inc. | Gilboa David Abraham | Co-CEO | S - Sale | $12.12 | -16,731 | 12,306 | -58% | -$202,780 | ||||||
2024-03-05 | WRBY | Warby Parker Inc. | Blumenthal Neil Harris | Co-CEO | S - Sale | $12.12 | -16,731 | 412,177 | -4% | -$202,780 | ||||||
| D | 2024-03-01 | RXST | Rxsight, Inc. | Thunen Shelley B | CFO | S - Sale+OE | $56.37 | -10,000 | 42,093 | -19% | -$563,726 | |||||
| DM | 2024-02-14 | RXST | Rxsight, Inc. | Goldshleger Ilya | COO | S - Sale+OE | $54.00 | -25,000 | 27,847 | -47% | -$1,350,000 | |||||
| M | 2024-02-12 | RXST | Rxsight, Inc. | Tammenoms Bakker Juliet | Dir | P - Purchase | $50.83 | +8,000 | 31,388 | +34% | +$406,673 | |||||
| D | 2024-02-09 | RXST | Rxsight, Inc. | Goldshleger Ilya | COO | S - Sale+OE | $50.74 | -10,365 | 27,847 | -27% | -$525,939 | |||||
| DM | 2024-02-05 | RXST | Rxsight, Inc. | Thunen Shelley B | CFO | S - Sale+OE | $47.31 | -25,000 | 55,784 | -31% | -$1,182,660 | |||||
2024-02-01 | RXST | Rxsight, Inc. | Link William J Phd | Dir | S - Sale | $49.67 | -28,250 | 45,797 | -38% | -$1,403,120 | ||||||
| D | 2024-02-01 | RXST | Rxsight, Inc. | Goldshleger Ilya | COO | S - Sale+OE | $49.29 | -7,129 | 27,847 | -20% | -$351,411 | |||||
2024-02-01 | RXST | Rxsight, Inc. | Weinberg Eric | Chief Commercial Officer | S - Sale | $50.00 | -10,000 | 307,131 | -3% | -$500,004 | ||||||
| D | 2024-01-26 | RXST | Rxsight, Inc. | Thunen Shelley B | CFO | S - Sale+OE | $47.11 | -31,772 | 35,193 | -47% | -$1,496,706 | |||||
2024-01-22 | RXST | Rxsight, Inc. | Weinberg Eric | Chief Commercial Officer | S - Sale | $48.00 | -10,000 | 317,131 | -3% | -$480,006 | ||||||
| D | 2024-01-22 | RXST | Rxsight, Inc. | Goldshleger Ilya | COO | S - Sale+OE | $48.00 | -5,000 | 27,847 | -15% | -$240,000 | |||||
2024-01-18 | RXST | Rxsight, Inc. | Maniar Shweta | Dir | S - Sale | $45.72 | -6,399 | 12,130 | -35% | -$292,555 | ||||||
2024-01-08 | STAA | Staar Surgical Co | Broadwood Partners, L.P. | 10% | P - Purchase | $27.11 | +4,042 | 21,562,760 | 0% | +$109,570 | ||||||
| D | 2024-01-09 | RXST | Rxsight, Inc. | Goldshleger Ilya | COO | S - Sale+OE | $47.00 | -5,000 | 27,847 | -15% | -$235,000 | |||||
2024-01-09 | RXST | Rxsight, Inc. | Weinberg Eric | Chief Commercial Officer | S - Sale | $46.00 | -10,000 | 327,131 | -3% | -$460,000 | ||||||
2024-01-08 | RXST | Rxsight, Inc. | Weinberg Eric | Chief Commercial Officer | S - Sale | $42.00 | -10,000 | 337,131 | -3% | -$420,000 | ||||||
2024-01-08 | RXST | Rxsight, Inc. | Warner Robert Keith | Dir | S - Sale | $42.69 | -23,750 | 27,733 | -46% | -$1,013,894 | ||||||
2024-01-08 | RXST | Rxsight, Inc. | Maniar Shweta | Dir | S - Sale | $45.00 | -6,418 | 18,529 | -26% | -$288,810 | ||||||
2024-01-08 | RXST | Rxsight, Inc. | Kurtz Ronald M Md | Pres, CEO | S - Sale | $44.25 | -62,500 | 844,610 | -7% | -$2,765,631 | ||||||
| D | 2024-01-08 | RXST | Rxsight, Inc. | Goldshleger Ilya | COO | S - Sale+OE | $43.33 | -15,000 | 27,850 | -35% | -$650,000 | |||||
2024-01-08 | RXST | Rxsight, Inc. | Corley Jesse Anderson | Dir | S - Sale | $45.03 | -2,000 | 513,340 | 0% | -$90,059 | ||||||
| M | 2024-01-03 | STAA | Staar Surgical Co | Broadwood Partners, L.P. | 10% | P - Purchase | $28.61 | +226,553 | 21,554,676 | +1% | +$6,481,557 | |||||
2024-01-04 | COO | Cooper Companies, Inc. | Petersmeyer Gary S | Dir | S - Sale | $336.03 | -150 | 4,961 | -3% | -$50,404 | ||||||
| D | 2024-01-02 | RXST | Rxsight, Inc. | Thunen Shelley B | CFO | S - Sale+OE | $39.24 | -10,000 | 30,693 | -25% | -$392,409 | |||||
2023-12-27 | RXST | Rxsight, Inc. | Kurtz Ronald M Md | Pres, CEO | S - Sale | $41.09 | -22,500 | 907,110 | -2% | -$924,498 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |